The Rest Is Science
The Rest Is Science

Nov 19, 2026 · 34 min

Cancer research maps disease from body-wide effects to prevention

Mapping Cancer’s Life Story

The episode shows how understanding cancer as an evolving, whole-body disease could reshape treatment, recurrence prevention, and future vaccines.

3 key takeaways
  1. 1Cachexia reveals how cancer disrupts metabolism, immunity, the brain, muscles, fat, and other organs beyond the tumor.
  2. 2PEACE and TRACERx track cancer’s evolution and spread, exposing differences between metastases and warning of future progression.
  3. 3LungVax, ecDNA research, and immune-based treatments point toward prevention and more precisely targeted therapies.

Don't miss

Mariam explains how PEACE autopsy research reveals that cancer metastases can differ across the body, potentially guiding more individualized treatment.

The brief

Professor Mariam Jamal-Hanjani traces lung cancer research from chemotherapy toward precision medicine, immunotherapy, and targeted radiotherapy, while challenging the idea that lung cancer only affects smokers.

Cachexia turns cancer into a whole-body problem: metabolism, immunity, the brain, muscles, fat, and other organs interact in a wasting syndrome that remains difficult to treat.

Team CanCan is testing treatments aimed at biological signals such as GDF15, but the episode stresses that cachexia will likely require several approaches rather than one fix.

PEACE and TRACERx reveal cancer as an evolving disease, using donated bodies and genetic changes to study metastases and identify risks before tumors appear on scans.

LungVax and ecDNA research extend that logic toward prevention and targeted treatment, while Mariam argues that collaboration and immune science make progress possible.

Weekly email

State of the Pod, every Monday

The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.

Listen to the full episode and explore every guest, topic, and moment on PodLume.